Features of the management of cancer patients during the COVID-19 pandemic

Novel coronavirus infection, causing COVID-19, is not fully controlled for today. In periodicals, there are often reports of a high risk of severe complications in cancer patients during the development of COVID-19. The review presents information from literary sources based on the experience gained in overcoming this formidable disease and its consequences using the examples of foreign colleagues of clinicians, as well as domestic experience and recommendations for the treatment of cancer during the pandemic COVID-19 of the National Medical Research Center for Radiology of the Ministry of Health of Russia with the participation and support of the Association of Oncologists of Russia and the Association of Health Organizers in Oncology. The information is based on actual data collected through the search of sources in abstract and sciencemetric electronic databases, open access resources in Russian and English. The review presents recommendations from international and domestic professional communities regarding the routing and multidisciplinary treatment of cancer patients during the pandemic period.

COVID-19, risk groups, hospital-acquired infection, fatality rate, oncological screening, temporary treatment regimens, chemotherapy, radiotherapy

1. World Health Organization Virtual press conference on COVID-19 — 11 March 2020. URL: https://www.who.int/docs/ default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020. pdf?sfvrsn=cb432bb3_2, free (accessed 06.04.2020).

2. Временные методические рекомендации Минздрава России «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 7 (03.06.2020). URL: http:// www.consultant.ru/document/cons_doc_LAW_354163/#dst0, свободный. Дата обращения: 06.06.2020.

3. Kamboj M., Sepkowitz K.A. Nosocomial infections in patients with cancer. Lancet Oncol. 2009; 10(6): 589–97. https://doi. org/10.1016/S1470-2045(09)70069-5 PMID: 19482247

4. Liang W. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3): 335–7. https://doi. org/10.1016/S1470-2045(20)30096-6 PMID: 32066541

5. ESMO. ESMO COVID-19 and cancer. URL: https://www. esmo.org/covid-19-and-cancer/q-a-on-covid-19, free (accessed 20.04.2020).

6. Gosain R., Abdou Y., Singh A., et al. COVID-19 and cancer: a comprehensive review. current oncology reports 2020 May 8; 22(5): 53. https://doi.org/10.1007/s11912-020-00934-7 PMID: 32385672

7. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). 16–24 February 2020. https://www.who.int/ docs/default-source/coronaviruse/who-china-joint-mission-oncovid-19-final-report.pdf, free (accessed 22.03.2020).

8. Yu J., Ouyang W., Chua M.L.K., Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020 Mar 25; 6(7): 1108–10. https://doi. org/10.1001/jamaoncol.2020.0980 PMID: 32211820

9. The Novel Coronavirus Pneumonia Emergency Response Epide miology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020. 2020 Feb 10; 41(2): 145–51. https://doi.org/10.3760/cma .j.issn.0254-6450.2020.02.003 PMID: 32064853 URL: https:// slma.lk/wp-content/uploads/2020/02/TheEpidemiologicalChara cteristicsofanOutbreakof2019NovelCoronavirusDiseases28COVID-1929E28094China2C20201.pdf, free (accessed 22.03.2020).

10. Desai A., Sachdeva S., Parekh T., Desai R. COVID-19 and cancer: lessons from a pooled meta-analysis. JCO Glob Oncol. 2020 Apr; 6:557–9. https://doi.org/10.1200/GO.20.00097 PMID: 32250659

11. Emami A., Javanmardi F., Pirbonyeh N., Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020 Mar 24; 8(1): e35. eCollection. https://doi.org/10.22037/ aaem.v8i1.600 PMID: 32232218

12. Hu Y., Sun J., Dai Z., et al. Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol. 2020 Jun; 127: 104371. https://doi.org/10.1016/j. jcv.2020.104371 PMID: 32315817

13. Richardson S., Hirsch J.S., Narasimhan M., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020 Apr 22; 323(20): 2052–9. https://doi.org/10.1001/ jama.2020.6775 PMID: 32320003

14. Grasselli G., Zangrillo A., Zanella A., et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020 Apr 6; 323(16): 1574–81. https://doi.org/10.1001/jama.2020.5394 PMID: 32250385

15. Onder G., Rezza G., Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020 Mar 23; 323(18): 1775–6. https://doi.org/10.1001/ jama.2020.4683 PMID: 32203977

16. Verity R., Okell L.C., Dorigatti I., et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020 Jun; 20(6): 669–77. https://doi.org/10.1016/ S1473-3099(20)30 243-7 PMID: 32240634

17. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep. ePub: 31 March 2020. 2020 Apr 3; 69(13): 382–6. https://doi.org/10.15585/mmwr.mm6913e2 PMID: 32240123

18. Zhang L., Zhu L., Xie C., et al. Clinical characteristics of COVID19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020 Jul; 31(7): 894–901. https://doi.org/10.1016/j.annonc.2020.03.296 PMID: 32224151

19. Dai M., Liu D., Liu M., et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov. 2020 Jun; 10(6): 783–91. https://doi.org/10.1158/2159-8290.CD-20-0422 PMID: 32345594

20. Miyashita H., Mikami T., Chopra N., et al. Do Patients with cancer have a poorer prognosis of COVID-19? An experience in New York city. Ann Oncol. 2020 Aug; 31(8): 1088–9. https://doi.org/10.1016/j.annonc.2020.04.006 PMID: 32330541

21. Mehta V., Goel S., Kabarriti R., et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020 Jul; 10(7): 935–41. https://doi.org/10.1158/2159- 8290.CD-20-0516 PMID: 32357994

22. U.S. Food & Drug Administration. FDA drug shortages. URL: https://www.accessdata.fda.gov/scripts/drugshortages/default. cfm, free (accessed 22.03.2020)

23. ASCO. ASCO coronavirus resources. URL: https://www.asco. org/asco-coronavirus-information, free (accessed 17.04.2020).

24. You B., Ravaud A., Canivet A., et al. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol. 2020 May; 21(5): 619–21. https://doi.org/10.1016/ S1470-2045(20)30204-7 PMID: 32220659

25. NCCN. Coronavirus disease 2019 (COVID-19) resources for the cancer care community. URL: https://www.nccn.org/covid-19/, free (accessed 12.04.2020).

26. ESMO. ESMO COVID-19 and cancer. URL: https://www.esmo. org/covid-19-and-cancer, free (accessed 20.04.2020).

27. Ontario Health Cancer Care Ontario. Pandemic planning clinical guideline for patients with cancer. URL: https://www.accc-cancer. org/docs/documents/cancer-program-fundamentals/oh-cco-pandemic-planning-clinical-guideline_final_2020-03-10.pdf, free (accessed 20.04.2020).

28. Al-Shamsi H.O., Alhazzani W., Alhuraiji A., et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist. 2020 Jun; 25(6): e936–45. https:// doi.org/10.1634/theoncologist.2020-0213 PMID: 32243668

29. American Society for Radiation Oncology (ASTRO). COVID-19 recommendations to radiation oncology practices. URL: https:// www.astro.org/Daily-Practice/COVID-19-Recommendationsand-Information, free (accessed 10.05.2020).

30. Каприн А.Д., Костин А.А., Пашигорова Л.В. и др. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) у онкологических больных. М.: ФГБУ «Национальный медицинский исследовательский Центр радиологии» Минздрава России, 2020. 18 с. URL: http://nmicr. ru/news/covid-19/_Covid_брошюра_%20FIN.pdf (дата обращения: 05.06.2020).

31. Cai Z.X., Wen W.Q., Min Z.J. Comparison of 5–FU-based and capecitabine-based neoadjuvant chemoradiotherapy in patients with rectal cancer: a meta-analysis. Clin Colorectal Cancer. 2017 Sep; 16(3): e123–39. https://doi.org/10.1016/j.clcc.2017.01.009 PMID: 28284574

32. Willan J., King A.J., Hayes S., et al. Care of haematology patients in a COVID-19 epidemic. Br J Haematol. 2020 Apr; 189(2): 241– 3. https://doi.org/10.1111/bjh.16620 PMID: 32173855

33. Centers for Disease Control and Prevention. CDC: COVID-19. URL: https://www.cdc.gov/coronavirus/2019-nCoV/index.html, free (accessed 26.04.2020).

34. American College of Surgeons. ACS: COVID-19 and surgery. URL: https://www.facs.org/covid-19/clinical-guidance, free (accessed 16.04.2020).

35. Liang W., Guan W., Chen R., et al. Cancer patients in SARSCoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 Mar; 21(3): 335–7. https://doi.org/10.1016/S1470- 2045(20)30096-6 PMID: 32066541

36. COVID-19 rapid guideline: delivery of systemic anticancer treatments NICE guideline [NG161] Published date: 20 March 2020. Last updated: 27 April 2020. URL: https://www.nice.org.uk/ guidance/ng161/resources/covid19-rapid-guideline-delivery-ofsystemic-anticancer-treatments-pdf-66141895710661, free (accessed 05.05.2020).

37. Interim treatment change options for the COVID-19 pandemic, endorsed by NHS England (27 April 2020). URL: https://www. nice.org.uk/guidance/ng161/resources/interim-treatment-changeoptions-during-the-covid19-pandemic-endorsed-by-nhs-englandpdf-8715724381, free (accessed 10.05.2020).

38. Чуа М.Л.К. Эффективный онкоцентр в эпоху COVID: опыт Китая и Сингапура. URL: http://www.protiv-raka.ru/effektivnyjonkocentr-v-epohu-covid-opyt-kitaya-i-singapura/, свободный (дата обращения: 06.06.2020).

39. Снеговой А.В., Кононенко И.Б., Корниецкая А.Л. и др. Рекомендации по профилактике и лечению нейтропении и анемии у онкопациентов в период пандемии COVID-19. URL: https://oncology-association.ru/files/pdf/2020/Rekomendacii_ AOR_po_FN_i_anemii.pdf, свободный (дата обращения: 10.06.2020).